Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1631.65
-2.75 (-0.17%)
< Home < Back

Sun Pharma receives observation from USFDA for plant in Gujarat

Date: 25-03-2019

Sun Pharmaceutical Industries has received one observation from US Food and Drug Administration (USFDA) for its Baska manufacturing facility in the state of Gujarat. The USFDA had conducted a pre-approval inspection (PAI) of Baska facility from January 28 to February 5, 2019.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.